FDA turns down Hetlioz for jet lag once again

FDA turns down Hetlioz for jet lag once again

Vanda Pharma may have forced the FDA to revisit its marketing application for Hetlioz as a therapy for jet lag, but the outcome has remained the same. Hetlioz (tasimelteon) has been approved in the US for a few years to treat sleep disorders affecting people who are blind or have the rare neurodevelopmental disorder Smith-Magenis…

Read More